The Risky Business of Drug Development- The Final Say of National Hta Agencies on A Pharmaceutical's Benefit During The Last Stretch of An Expensive, Long-Lasting And Arduous Development Journey – As Illustrated By The Decisions Of Germany' ...
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.1146
https://www.valueinhealthjournal.com/article/S1098-3015(14)03076-9/fulltext
Section Title :
Health Care Use and Policy Studies
Section Order :
647
First Page :
A439
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03076-9&doi=10.1016/j.jval.2014.08.1146